南方医科大学学报 ›› 2005, Vol. 25 ›› Issue (11): 1348-1351.

• • 上一篇    下一篇

突变低氧诱导因子1α基因真核表达载体的构建和表达

傅锐斌1, 吴平生2, 宋云峰1, 邱建1, 戴铁英2, 李建华2, 修建成2   

  1. 1. 广州军区广州总医院心内科, 广东, 广州, 510010;
    2. 南方医科大学南方医院心内科, 广东, 广州, 510515
  • 出版日期:2005-11-20 发布日期:2005-11-20
  • 基金资助:
    收稿日期:2005-6-7。
    基金项目:国家自然科学基金项目(30370587);广东省科技计划项目(C31206)
    作者简介:傅锐斌(1974-),男,2003年毕业于第一军医大学,硕士,主治医师,电话:020-36653366,E-mail:furb7@sohu.com

Construction of eukaryotic expression vectors of two mutants of hypoxia-inducible factor-1 and their expressions in human microvascular endothelial cells

FU Rui-bin1, WU Ping-sheng2, SONG Yun-feng1, QIU Jian1, DAI Tie-ying2, LI Jian-hua2, XIU Jian-cheng2   

  1. 1. 广州军区广州总医院心内科, 广东, 广州, 510010;
    2. 南方医科大学南方医院心内科, 广东, 广州, 510515
  • Online:2005-11-20 Published:2005-11-20

摘要: 目的 构建人低氧诱导因子-1α(HIF-1α)真核表达载体pcDNA3.1+-HIF-1α的两种突变体pcDNA3.1+-HIF-1α-564Ala和pcDNA3.1+-HIF-1α-564Ala-803Ala,并检测它们在人肺微血管内皮细胞(HMVECs)中的表达。方法 用定点突变的方法将pcDNA3.1+-HIF-1α的HIF-1α第564位脯氨酸(Pro)密码子CCC突变为丙氨酸(Ala)密码子GCC,构建成单个突变HIF-1α真核表达载体pcDNA3.1+-HIF-1α-564Ala。在第一次突变的基础上,仍然用定点突变的方法将pcDNA3.1+-HIF-1α-564Ala的HIF-1α-564Ala第803位天冬酰胺(Asn)密码子ATT突变为丙氨酸(Ala)密码子GCT,构建成双个点突变HIF-1α真核表达载体pcDNA3.1+-HIF-1α-564Ala-803Ala。将3种HIF-1α表达载体用脂质体法分别转入HMVECs,以RT-PCR、免疫荧光法和Westernblotting法分别对转染细胞进行表达分析。结果 测序证实,定点突变成功,构建成重组真核表达载体pcDNA3.1+-HIF-1α-564Ala和pcDNA3.1+-HIF-1α-564Ala-803Ala;3种载体均能表达相应的蛋白和mRNA,但转化突变HIF-1α表达载体的细胞蛋白量比空白细胞和转化无突变HIF-1α载体的细胞显著增加。结论 成功构建能够在HMVECs中表达的单个和双个点突变的HIF-1α基因的真核表达载体。

Abstract: Objective To construct eukaryotic expression vectors of two mutants of hypoxia-inducible factor-1 (HIF-1α) and study their expressions in human microvascular endothelial cells (HMVECs). Methods Site-directed mutagenesis was performed to induce the mutation of the codons for the residue Pro564 (ccc) in HIF-1α into gcc (Ala) in pcDNA3.1+-HIF-1α to obtain single-site-mutated vector pcDNA3.1+-HIF-1α-564Ala, which was then subjected to a second site-directed mutagenesis to convert the codons for Asn803 into that of Ala (gct) to acquire double-site-mutated pcDNA3.1+-HIF-1α-564Ala-803Ala. After lipofectin-mediated transient transformation of HMVECs with the 3 recombinant plasmids including the two plasmids containing the mutations and the one without mutation, respectively, the expression levels of HIF-1α mRNA and protein were determined using RT-PCR, immunofluorescent staining and Western blotting. Results DNA sequence analysis demonstrated success of the two-step mutagenesis and the two plasmids of pcDNA3.1+-HIF-1α-564Ala and pcDNA3.1+-HIF-1α-564Ala- 803Ala were obtained, both of which could produce HIF-1α protein resistant to oxidation degradation in HMVECs as compared with the non-mutated one. Conclusion The recombinant plasmids pcDNA3.1+-HIF-1α-564Ala and pcDNA3.1+-HIF-1α- 564Ala-803Ala have been successfully constructed with efficient expressions in HMVECs.

中图分类号: